Loading company…
Riskpilot
← Back to search
Sign in
Get full access
VILAS PHARMACEUTICAL SERVICES ApS
APS
Active
CVR 35648275
Vermehrensvej 8
Business and other management consultancy activities · NACE 7020
Est. 2014
2 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
DKK 1,1M
+5% vs 2024
EBITDA margin
13.2%
-26% vs 2024
Equity ratio
83.9%
Financial strength
Net profit 2025
DKK 102K
-39% vs 2024
EBITDA — year on year
DKK millions
1M
1M
1M
0M
0M
0M
2021
0M
0%
2022
1M
+100%
2023
0M
-100%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
DKK 1,1M
+5%
EBITDA
DKK 146K
-26%
Net profit
DKK 102K
-39%
Total assets
DKK 886K
-1%
Equity
DKK 743K
-3%
Employees
2
—
Company information
Legal name
VILAS PHARMACEUTICAL SERVICES ApS
CVR number
35648275
Legal form
Anpartsselskab
NACE code
7020 · Business and other management consultancy activities
Founded
20. januar 2014
Share capital
DKK 50.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-05-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Company purpose
Selskabets formål er rådgivning, handel og service samt aktiviteter i tilknytning hertil
Contact
Address
Vermehrensvej 8
Phone
+4526135309
Email
info@vilaspharma.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Business and other management consultancy activities
Companies in Ringsted
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
1M
2023
1M
2024
1M
2025
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
1M
2023
0M
2024
0M
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Revenue
978
712
1.287
1.052
1.104
Staff expenses
-593
-625
-760
-857
-959
EBITDA
385
86
527
196
146
Depreciation & amort.
-51
-46
-46
-0
-0
EBIT
334
40
481
196
146
Net financials
44
7
-28
16
2
Profit before tax
378
47
452
212
148
Tax
85
17
108
45
46
Net profit
293
30
345
167
102
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
1.141
711
962
891
886
Equity
616
533
764
763
743
Long-term debt
0
0
0
0
0
Short-term debt
521
165
192
115
134
Total debt
521
165
192
115
134
Financial ratios
5-year trend
EBITDA margin
13.2%
This company
15.8%
Market median
-16% vs market
2021
2025
Equity ratio
83.9%
This company
38.2%
Market median
+120% vs market
2021
2025
Return on equity
13.7%
This company
18.4%
Market median
+26% vs market
2021
2025
Net profit margin
9.2%
This company
8.1%
Market median
+14% vs market
2021
2025
Asset turnover
1.25×
This company
1.12×
Market median
+12% vs market
2021
2025
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-06-01 – 2025-05-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-06-01 – 2024-05-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-06-01 – 2023-05-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-06-01 – 2022-05-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-06-01 – 2021-05-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Nicolaj Donskov Nielsen
Individual
100%
100%
2014
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
VILAS PHARMACEUTICAL SERVICES ApS
(this company)
Donskov Boligadministration ApS
NG2X Pharma ApS
Board network connections
Board members of VILAS PHARMACEUTICAL SERVICES ApS also hold positions in
0
other companies.
Person
Role here
Other companies